SCHEMBL20230610

SCHEMBL20230610

CC1(C)c2ccccc2N(c2ccccc2)c2cc(-c3ccc4c(c3)Oc3cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc3O4)ccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 3/20 0.33
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 3/20 0.33
CYP2D6 P10635 3/20 0.33
CYP2C19 P33261 3/20 0.33
HSD17B10 Q99714 3/20 0.33
CLK4 Q9HAZ1 3/20 0.33
ALOX15 P16050 2/20 0.33
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
LMNA P02545 1/20 0.33
CYP2C9 P11712 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
PKM P14618 1/20 0.32
POLB P06746 2/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20230588 0.94 LMNA (0.31) USP2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL20230635 0.94 ADORA2A (0.35) USP2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL20230609 0.93 USP2 (0.34) USP2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL20230617 0.92 USP2 (0.33) USP2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL20230605 0.90 POLB (0.35) USP2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL20230567 0.89 ADORA2A (0.33) USP2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL20230572 0.89 USP2 (0.32) USP2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL20230652 0.89
SCHEMBL20230624 0.88 HPSE (0.33) USP2CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL20230696 0.88 ADORA2A (0.32) USP2CYP1A2CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CCNT1 USP2 3860/4885CYP1A2 1512/4885CYP3A4 2461/4885
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CCNT1 USP2 3860/4885CYP1A2 1512/4885CYP3A4 2461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.